Skip to main content
Toggle navigation
Search
Home
Home
Type here to filter the list
Thursday, May 29th
8:30 AM - 9:15 AM
East Coast USA Time
Dolores Shockley Diversity and Inclusion in Clinical Research Award Lecture
Location: Woodrow Wilson
Award Lecturer:
Nita A. Limdi, PharmD, PhD, MPH
– University of Alabama at Birmingham
Award Presenter:
Matthew L. Rizk, PhD
– Merck
Pharmacogenomics (PGx)
Specific Populations (SPO)
Thursday, May 29th
11:00 AM - 12:00 PM
East Coast USA Time
Challenges and Opportunities of RNA Therapeutics, A Roller Coaster from Discovery to Recovery II: Translational Science with an Emphasis on Special Populations
Location: National Harbor 11
Chair:
Bianca D. van Groen, PharmD, PhD (she/her/hers)
– Roche
Chair:
Sandra A.G Visser, PhD (she/her/hers)
– Alltrna
Speaker:
Patricia Sanwald-Ducray, PharmD, PhD (she/her/hers)
– Roche
Speaker:
Nina Isoherranen, PhD (she/her/hers)
– University of Washington
Speaker:
Farzaneh Salem, PharmD, PhD (she/her/hers)
– GlaxoSmithKline
Specific Populations (SPO)
Physiological Based Pharmacokinetic Modeling and Simulation (PBPK)
Friday, May 30th
8:15 AM - 9:15 AM
East Coast USA Time
Global Strategies for Clinical Pharmacology and Labelling in the Treatment of Mental Disorders in Pregnant and Lactating People
Location: National Harbor 10
Chair:
Kristin Bigos, PhD
– Johns Hopkins School of Medicine
Chair:
Farzaneh Salem, PharmD, PhD (she/her/hers)
– GlaxoSmithKline
Speaker:
Lindsay Standeven, MD
– Johns Hopkins
Speaker:
Xian Pan, PhD (she/her/hers)
– Simcyp, Certara UK Ltd
Speaker:
Venkateswaran Chithambaram Pillai, PhD
– US Food and Drug Administration
Specific Populations (SPO)
Mental Health & Addiction (MHA)
Friday, May 30th
11:00 AM - 12:00 PM
East Coast USA Time
GLP-1 Agonists for Addiction: A Novel Therapeutic Approach Toward Recovery for an Undertreated Disorder
Location: National Harbor 11
Chair:
Vijay A. Ramchandani, PhD (he/him/his)
– National Institute on Alcohol Abuse and Alcoholism
Chair:
Susan M. Learned, MD, PharmD, PhD (she/her/hers)
– Learned Consulting Group, LLC
Speaker:
Lorenzo Leggio, MD, PhD (he/him/his)
– National Institute on Drug Abuse
Speaker:
Michael Bremmer, PhD (he/him/his)
– University of North Carolina at Chapel Hill
Speaker:
Scott C. Bunce, PhD (he/him/his)
– Penn State College of Medicine
Mental Health & Addiction (MHA)
Specific Populations (SPO)
Friday, May 30th
1:30 PM - 2:15 PM
East Coast USA Time
Rawls-Palmer Progress in Medicine Award Lecture
Location: National Harbor 10
Award Lecturer:
Janice B. Schwartz, MD (she/her/hers)
– University of California, San Francisco
Award Presenter:
Leslie Z. Benet, PhD (he/him/his)
– University of California, San Francisco
Specific Populations (SPO)
Physiological Based Pharmacokinetic Modeling and Simulation (PBPK)
Friday, May 30th
3:00 PM - 4:00 PM
East Coast USA Time
Advancing Decentralized Clinical Trials for Rare Diseases and Special Populations: Perspectives and Opportunities
Location: National Harbor 10
Chair:
Jackson K. Burton, PhD (he/him/his)
– Biogen
Chair:
Katty Wan, PhD (she/her/hers)
– Pfizer
Speaker:
Michelle Lorenz (she/her/hers)
– Voices for ALS
Speaker:
Laura Shaughnessy, PhD
– UCB Biosciences, Inc
Speaker:
Elimika Fletcher, PharmD, PhD
– US Food and Drug Administration
Specific Populations (SPO)
Rare Diseases (RD)